Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HK:1167
Stock Latest News
Company Announcements
Jacobio Boosts Share Buybacks and Liquidity as Oncology Pipeline Advances
5d ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Sets 2026 AGM, Seeks Fresh Share Issuance Mandate
29d ago
1167
Premium
Company Announcements
Jacobio Secures US$100 Million Upfront From AstraZeneca for Pan-KRAS Cancer Drug
2M ago
1167
Premium
Ratings
Jacobio Pharma: Differentiated Pan-KRAS Profile, Multiple Clinical Catalysts, and Solid Balance Sheet Underscore Buy Rating
2M ago
Premium
Company Announcements
Jacobio Wins China KRAS Drug Approval and Strikes US$2 Billion AstraZeneca Deal
2M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results
3M ago
1167
Premium
Company Announcements
Jacobio’s First-in-Human JAB-8263 Trial Moves Forward, Keeping Oncology Pipeline in Focus
4M ago
1167
Premium
Company Announcements
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
4M ago
1167
Premium
Company Announcements
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
5M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
6M ago
1167
Premium
Company Announcements
Jacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
6M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
6M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
7M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
7M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
7M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
7M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
7M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
8M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
9M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
9M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Establishes Nomination Committee to Enhance Governance
9M ago
1167
Premium
Company Announcements
Jacobio Pharmaceuticals Announces Board Meeting for Interim Results
9M ago
1167
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
